ESC 365 - Who should be treated with an SGLT2 inhibitor?

ESC Premium Access

Who should be treated with an SGLT2 inhibitor?

Session: Everything you need to know about SGLT2 inhibitors in heart failure

Topic: Chronic Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

Event: ESC Congress 2021 - The Digital Experience

Presentation

About the speaker

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)

82 presentations

2 followers

3 more presentations in this session

SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?

Speaker: Doctor K. Damman (Groningen, NL)

SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

Speaker: Professor A. Cahn (Jerusalem, IL)

Everything you need to know about SGLT2 inhibitors in heart failure – discussion.

Access the full session

Everything you need to know about SGLT2 inhibitors in heart failure

Speakers: Professor J. McMurray, Doctor K. Damman, Professor A. Cahn

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

ESC Premium Access

Congenital isolated bilateral upper pulmonary veins atresia - oligosymptomatic adult patient case report.

27 August 2021

This platform is supported by